179 related articles for article (PubMed ID: 24088023)
1. Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials.
Yang J; Cui X; Li J; Zhang C; Zhang J; Liu M
Dev Neurorehabil; 2015; 18(5):330-5. PubMed ID: 24088023
[TBL] [Abstract][Full Text] [Related]
2. Edaravone for acute intracerebral haemorrhage.
Yang J; Liu M; Zhou J; Zhang S; Lin S; Zhao H
Cochrane Database Syst Rev; 2011 Feb; (2):CD007755. PubMed ID: 21328300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of therapies for acute ischemic stroke in China: a network meta-analysis of 13289 patients from 145 randomized controlled trials.
Yang B; Shi J; Chen X; Ma B; Sun H
PLoS One; 2014; 9(2):e88440. PubMed ID: 24551100
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
Tanahashi N; Yamaguchi T; Awano H; Matsuda H
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
[TBL] [Abstract][Full Text] [Related]
6. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
7. Edaravone: a new therapeutic approach for the treatment of acute stroke.
Kikuchi K; Kawahara K; Miyagi N; Uchikado H; Kuramoto T; Morimoto Y; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada K; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
[TBL] [Abstract][Full Text] [Related]
8. The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage.
Shang H; Cui D; Yang D; Liang S; Zhang W; Zhao W
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):215-22. PubMed ID: 25440340
[TBL] [Abstract][Full Text] [Related]
9. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
[TBL] [Abstract][Full Text] [Related]
10. Edaravone for acute ischaemic stroke.
Feng S; Yang Q; Liu M; Li W; Yuan W; Zhang S; Wu B; Li J
Cochrane Database Syst Rev; 2011 Dec; (12):CD007230. PubMed ID: 22161410
[TBL] [Abstract][Full Text] [Related]
11. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
Edaravone Acute Infarction Study Group
Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
[TBL] [Abstract][Full Text] [Related]
12. Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study.
Naritomi H; Moriwaki H; Metoki N; Nishimura H; Higashi Y; Yamamoto Y; Yuasa H; Oe H; Tanaka K; Saito K; Terayama Y; Oda T; Tanahashi N; Kondo H;
Drugs R D; 2010; 10(3):155-63. PubMed ID: 20945946
[TBL] [Abstract][Full Text] [Related]
13. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Lapchak PA
Expert Opin Pharmacother; 2010 Jul; 11(10):1753-63. PubMed ID: 20491547
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
15. Edaravone offers neuroprotection for acute diabetic stroke patients.
Zheng J; Chen X
Ir J Med Sci; 2016 Nov; 185(4):819-824. PubMed ID: 26597952
[TBL] [Abstract][Full Text] [Related]
16. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
17. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.
Nakase T; Yoshioka S; Suzuki A
BMC Neurol; 2011 Mar; 11():39. PubMed ID: 21447190
[TBL] [Abstract][Full Text] [Related]
18. Edaravone Mitsubishi-Tokyo.
Tabrizchi R
Curr Opin Investig Drugs; 2000 Nov; 1(3):347-54. PubMed ID: 11249718
[TBL] [Abstract][Full Text] [Related]
19. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
Green AR; Ashwood T
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
[TBL] [Abstract][Full Text] [Related]
20. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
